Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedernews.google.com
Get the latest updates from Biosimilar IQWiG DAHTA Germany reimbursement - Google News directly as they happen.
Follow now < 10 followers
Last updated about 3 years ago
about 3 years ago
Three pillars of post-pandemic launch excellence - pharmaphorum
about 3 years ago
2021 market access prospects for Germany - pharmaphorum
over 3 years ago
Zolgensma Loses Orphan Benefit in Germany After 'Very High Sales' Pink Sheet
over 3 years ago
Gilead buying German biotech The Pharma Letter
over 3 years ago
Comparator Issues Thwart Cosentyx Benefit Assessment In Germany Pink Sheet
over 3 years ago
German Insurers Want End To Free Pricing In Amnog Review Pink Sheet
over 3 years ago
Ibrance misses main endpoint in breast cancer study The Pharma Letter
over 3 years ago
Improve Access to RWD In Asia To Make RWE Viable Pink Sheet
over 3 years ago
Germany Sets Direction Of Travel With New Biosimilar Guidelines Pink Sheet
over 3 years ago
Savara's molgramostim seen to benefit people with aPAP The Pharma Letter
over 3 years ago
Talazoparib shows hint of considerable added benefit in breast cancer, says IQWiG...
over 3 years ago
Edited Transcript of UCB.BR earnings conference call or presentation 27-Jul-20 12:00pm GMT...